Drug Information

Drug General Information
Drug ID
D0X7JN
Former ID
DAP000948
Drug Name
Clavulanate
Synonyms
Clavulansaeure; Clavulox; Acide clavulanique; Acido clavulanico; Acidum clavulanicum; CLAVULANIC ACID; Clavulansaeure [INN]; Clavulinic Acid; Sodium Clavulanate; Antibiotic MM 14151; MM 14151; Acide clavulanique [INN-French]; Acido clavulanico [INN-Spanish]; Acidum clavulanicum [INN-Latin]; BRL-14151; Clavulanic acid (INN); Clavulanic acid [BAN:INN]; Clavulox (TN); MM-14151; (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (Z)-(2R,5R)-3-(2-Hydroxyethyliden)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptan-2-carbonsaeure; (Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid; 3008-B; 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, (2R-(2alpha,3Z,5alpha))
Drug Type
Small molecular drug
Indication Bacterial infections [ICD9: 001-009, 010-018, 020-027, 030-041, 080-088, 090-099, 100-104; ICD10:A00-B99] Approved [538214]
Therapeutic Class
Antibiotics
Company
GlaxoSmithKline
Structure
Download
2D MOL

3D MOL
Formula
C8H9NO5
Canonical SMILES
C1C2N(C1=O)C(C(=CCO)O2)C(=O)O
InChI
1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1
InChIKey
HZZVJAQRINQKSD-PBFISZAISA-N
CAS Number
CAS 58001-44-8
PubChem Compound ID
5280980
PubChem Substance ID
8887, 618290, 8616466, 15120937, 15171670, 24277226, 39289932, 46508845, 47960009, 48415790, 49693459, 49999546, 51092007, 57357956, 78036519, 103205106, 103932648, 113854329, 124361166, 124361169, 124361172, 124766056, 124899393, 126686128, 127325992, 127325993, 127325994, 127325995, 134224530, 134338222, 135004531, 137156469, 140243917, 160964109, 163408941, 163848076, 164807987, 170539111, 175268707, 175442211, 179293309, 196392708, 223554933, 223674816, 223744246, 226397639, 226420758, 250136745, 251916653, 251917908
ChEBI ID
ChEBI:48947
Target and Pathway
Target(s) Beta-lactamase Target Info Inhibitor [537436]
References
Ref 538214FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 065063.
Ref 537436A sensitive coupled HPLC/electrospray mass spectrometry assay for SPM-1 metallo-beta-lactamase inhibitors. Assay Drug Dev Technol. 2009 Apr;7(2):170-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.